Medical technology company Becton Dickson & Co. (BD) says it received approval from the Food and Drug Administration for a two-hour test to identify strains of staph infections. The company s San ...
Shares of Becton Dickinson hit an all-time high yesterday after the company won the right to market the first rapid blood test that can distinguish between deadly, drug-resistant staph infections and ...
WASHINGTON (Reuters) - A company that harnesses bacteria-killing viruses said on Saturday it has devised a test that can detect dangerous staph infections within hours. This could allow doctors to ...
Hosted on MSN
Color test 'sniffs out' dangerous staph strains fast
Researchers have developed a rapid color-changing test that can distinguish between different strains of golden staph, including those likely to be virulent and antibiotic resistant. Golden staph is a ...
Using rapid diagnostic tests and algorithms to make suggestions on how to best use antibiotics helped reduce the amount of days people needed to stay on them, a new report finds. The study was ...
CHICAGO, Jan 2 (Reuters) - Becton, Dickinson and Co on Wednesday said it received clearance from the U.S. Food and Drug Administration for a test to identify the presence of two deadly ...
Becton, Dickinson and Co on Wednesday said it received clearance from the Food and Drug Administration for a test to identify the presence of two deadly healthcare-associated infections: ...
Researchers have developed a faster and more effective method of detecting Staphylococcus aureus (golden staph) infections than traditional, resource-intensive tests. Using a process called mass ...
Antibiotic-resistant infections should be easier to detect, and hospitals could become safer, thanks to a technology developed by the Translational Genomics Research Institute (TGen) and Northern ...
It's a silent, nationwide epidemic. Virulent, drug-resistant strains of staphylococcus bacteria are rapidly spreading in many communities. Implicated in 126,000 hospitalizations a year, the germ can ...
A new bioengineered drug candidate demonstrated superior performance to a standard antibiotic at treating mice infected with Staphylococcus aureus, according to results from early testing published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results